MedPath
TGA Approval

RESTEASE doxylamine succinate 25mg tablet blister pack (400390)

400390

RESTEASE doxylamine succinate 25mg tablet blister pack

AUBEX PHARMA Pty Ltd

November 30, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

doxylamine succinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.